A multicenter observational study of the real‐world use of docetaxel for metastatic castration‐resistant prostate cancer in China

A multicenter observational study of the real‐world use of docetaxel for metastatic castration‐resistant prostate cancer in China

Aim To investigate the use of docetaxel for the treatment of metastatic castration‐resistant prostate cancer (mCRPC) in real‐world clinical practice in China. Methods This single‐arm, prospective, observational study was conducted at 32 study centers in China and included male patients aged ≥18 year...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Asia-Pacific journal of clinical oncology 2019-06, Vol.15 (3), p.144-150
Hauptverfasser: He, Dalin, Sun, Zhongquan, Guo, Jianming, Zhang, Zhigen, Shan, Yuxi, Ma, Lulin, Li, Hanzhong, Jin, Jie, Huang, Yiran, Xiao, Jiaquan, Wei, Qiang, Ye, Dingwei
Format: Artikel
Sprache:eng
Schlagworte:
Adenocarcinoma - drug therapy
Adult
Aged
Aged, 80 and over
Antineoplastic Agents - therapeutic use
Castration
castration‐resistant prostate cancer
China
Disease Progression
docetaxel
Docetaxel - therapeutic use
Humans
Leukopenia
Male
Metastases
Metastasis
Middle Aged
observational
Observational studies
Original
Patients
Prospective Studies
Prostate cancer
Prostate-Specific Antigen - blood
Prostatic Neoplasms, Castration-Resistant - drug therapy
Testosterone
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Aim To investigate the use of docetaxel for the treatment of metastatic castration‐resistant prostate cancer (mCRPC) in real‐world clinical practice in China. Methods This single‐arm, prospective, observational study was conducted at 32 study centers in China and included male patients aged ≥18 years with histologically confirmed prostate cancer who received ≥1 dose of docetaxel following failure of hormonal therapy (disease progression with serum testosterone
ISSN:1743-7555
1743-7563
DOI:10.1111/ajco.13142